For treatment of hyperuricemia in patients with gout, Febs is recommended. Gout flares may occur after initiation of Febs due to changing serum uric acid levels resulting in mobilization of urate from tissue deposits. Flare prophylaxis with a non-steroidal anti-inflammatory drug (NSAID) or colchicine is recommended upon initiation of Febs. Prophylactic therapy may be beneficial for upto six months. If a gout flare occurs during Febs treatment, Febs need not be discontinued. The gout flare should be managed concurrently, as appropriate for the individual patient.
This medication is an iron supplement used to treat or prevent low blood levels of iron (e.g., for anemia or during pregnancy). Ascorbic acid (vitamin C) improves the absorption of iron from the stomach.